There are 2137 resources available
1940P - CALIBRATION: Can early changes in circulating tumour DNA (ctDNA) predict durable tumour responses in patients (pts) with advanced esophageal adenocarcinoma (EAC) receiving anti PD-L1 antibody durvalumab (D)?
Presenter: Constanza Linossi
Session: E-Poster Display
Resources:
Abstract
1942P - IL6 pre-treatment promotes chemosensitivity by eliminating quiescent cancer stem cells
Presenter: Xin Wang
Session: E-Poster Display
Resources:
Abstract
1943P - TERT-associated DNA polymerases genes link CD8+ T cells to improve immunotherapy response rate
Presenter: Zhiwen Luo
Session: E-Poster Display
Resources:
Abstract
1944P - Hyperglycemia increased nivolumab-induced cardiotoxicity, enhanced immunoresistance of ERɑ+, PR+, HER2- breast cancer cells modulating growth factors and NLRP3 expression
Presenter: Vincenzo Quagliariello
Session: E-Poster Display
Resources:
Abstract
1945P - Distribution of anti-PD1/PDL1 autoantibodies in multiple cancer types and potential biomarker role for anti-PD1 therapy
Presenter: Qiaoyun Tan
Session: E-Poster Display
Resources:
Abstract
1946P - Dysregulation of immune checkpoint proteins in newly- diagnosed early breast cancer patients
Presenter: Bernardo Rapoport
Session: E-Poster Display
Resources:
Abstract
1947P - Single cell analysis reveals that CD8+ T cell clone size determines response to immune checkpoint blockade
Presenter: Robert Watson
Session: E-Poster Display
Resources:
Abstract
1948P - Characterising the peripheral myeloid response to immune checkpoint blockade
Presenter: Rosalin Cooper
Session: E-Poster Display
Resources:
Abstract
1949P - Immune suppressive tumour microenvironment and inferior survival of PIK3CG or PIK3CD high expression group in TCGA-Pan cancer cohort
Presenter: Bum-sup Jang
Session: E-Poster Display
Resources:
Abstract
1950P - TRANSLATE: Activation of immune response in refractory patients to standard treatment
Presenter: Marco Merlano
Session: E-Poster Display
Resources:
Abstract